Despite passing the effectiveness test with an outstanding score of 90.4 percent, Novavax's unclear route to approval in the United States may see India emerge as a significant destination for the injections, with the Serum Institute of India as a manufacturing partner.
Shortly after the second wave of the COVID-19 left the nation devastated, the 'Delta Plus' variant has made itself known in countries across the world. How much of a threat does the Delta Plus variant of the Coronavirus pose?
